As scientific research continues to produce studies on the health benefits of cannabis and CBD and legalization of the plant grows across the globe, not unsurprisingly traditional investment firms are dipping their collective toes into the market.
To partake in this profitable sector, Brazilian investment management company XP Inc. XP created the allocation vehicle Trend Cannabis FIM in 2019, which allows people to invest in the industry starting with as little as 100 Brazilian reales, or nearly $18.56, reported Brazilian financial site FDR.
Focused on the international cannabis market, Trend Cannabis FIM will invest in shares of companies from the U.S., England and Canada.
Intended for general investors, Trend Cannabis will passively invest in an ETF called ETFMG Alternative Harvest MJ MJ, which is listed in the U.S.
Alternative Harvest, the largest and most liquid ETF linked to the U.S. cannabis sector, applies to shares of companies directly or indirectly related to the process of legal cultivation, marketing, production or distribution of marijuana products.
Connected to both medicinal and recreational cannabis Alternative Harvest is considered to be among the best marijuana ETFs with over $1 billion in assets.
The fund’s portfolio, with 37 positions including exposure to the U.S. dollar and British pound, is diversified, with its top 10 holdings amassing 58% of its assets.
ETFMG includes the largest names in cannabis, such as Cronos Group Inc. CRON, which is its largest position, as well as Aurora Cannabis ACB, Canopy Growth CGC and CannTrust Holdings CNTTQ.
Out of 37 positions in ETFMG Alternative Harvest ETF’s portfolio, only 11 are pure-play marijuana stocks. The rest of the positions include pharmaceutical companies that develop or sell cannabis-based drugs, such as Jazz Pharmaceuticals plc, JAZZ formerly GW Pharmaceuticals and Cara Therapeutics Inc. CARA.
Photo courtesy of Wikipedia
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF